BACKGROUND: Heart failure (HF) is associated with an overall stroke rate that is too low to justify anticoagulation in all patients. This study was conducted to determine if vascular risk factors can identify a subgroup of individuals with heart failure with a stroke rate high enough to warrant anticoagulation. METHODS: The REGARDS study is a population-based cohort of US adults aged ≥45 years. Participants are contacted every 6 months by telephone for self- or proxy-reported stroke and medical records are retrieved and adjudicated by physicians. Participants were characterized into 3 groups: HF without atrial fibrillation (AF), AF with or without HF, and neither HF nor AF. Cardiovascular risk factors at baseline were compared between participants with and without incident stroke in HF and AF. Stroke incidence was assessed in risk factor subgroups in HF participants. RESULTS: Of the 30,239 participants, those with missing/anomalous data were excluded. Of the remaining 28,832, 1360 (5%) had HF without AF, 2528 (9%) had AF, and 24,944 (86%) had neither. Previous stroke/transient ischemic attack (TIA; P = .0004), diabetes mellitus (DM; P = .03), and higher systolic blood pressure (P = .046) were associated with increased stroke risk in participants with HF without AF. In participants with HF without AF, stroke incidence was highest in those with previous stroke/TIA and DM (2.4 [1.1, 4.0] per 100 person-years). CONCLUSIONS: The combination of previous stroke/TIA and DM increases the incidence of stroke in participants with HF without AF. No analyzed subgroup had a stroke rate high enough to make it likely that the benefits of warfarin would outweigh the risks.
BACKGROUND:Heart failure (HF) is associated with an overall stroke rate that is too low to justify anticoagulation in all patients. This study was conducted to determine if vascular risk factors can identify a subgroup of individuals with heart failure with a stroke rate high enough to warrant anticoagulation. METHODS: The REGARDS study is a population-based cohort of US adults aged ≥45 years. Participants are contacted every 6 months by telephone for self- or proxy-reported stroke and medical records are retrieved and adjudicated by physicians. Participants were characterized into 3 groups: HF without atrial fibrillation (AF), AF with or without HF, and neither HF nor AF. Cardiovascular risk factors at baseline were compared between participants with and without incident stroke in HF and AF. Stroke incidence was assessed in risk factor subgroups in HF participants. RESULTS: Of the 30,239 participants, those with missing/anomalous data were excluded. Of the remaining 28,832, 1360 (5%) had HF without AF, 2528 (9%) had AF, and 24,944 (86%) had neither. Previous stroke/transient ischemic attack (TIA; P = .0004), diabetes mellitus (DM; P = .03), and higher systolic blood pressure (P = .046) were associated with increased stroke risk in participants with HF without AF. In participants with HF without AF, stroke incidence was highest in those with previous stroke/TIA and DM (2.4 [1.1, 4.0] per 100 person-years). CONCLUSIONS: The combination of previous stroke/TIA and DM increases the incidence of stroke in participants with HF without AF. No analyzed subgroup had a stroke rate high enough to make it likely that the benefits of warfarin would outweigh the risks.
Authors: Virginia J Howard; Dawn O Kleindorfer; Suzanne E Judd; Leslie A McClure; Monika M Safford; J David Rhodes; Mary Cushman; Claudia S Moy; Elsayed Z Soliman; Brett M Kissela; George Howard Journal: Ann Neurol Date: 2011-03-17 Impact factor: 10.422
Authors: J F Meschia; T G Brott; F E Chukwudelunzu; J Hardy; R D Brown; I Meissner; L J Hall; E J Atkinson; P C O'Brien Journal: Stroke Date: 2000-05 Impact factor: 7.914
Authors: John S Gottdiener; Robyn L McClelland; Robert Marshall; Lynn Shemanski; Curt D Furberg; Dalane W Kitzman; Mary Cushman; Joseph Polak; Julius M Gardin; Bernard J Gersh; Gerard P Aurigemma; Teri A Manolio Journal: Ann Intern Med Date: 2002-10-15 Impact factor: 25.391
Authors: Brian F Gage; Carl van Walraven; Lesly Pearce; Robert G Hart; Peter J Koudstaal; B S P Boode; Palle Petersen Journal: Circulation Date: 2004-10-11 Impact factor: 29.690
Authors: Patrick M Pullicino; Min Qian; Ralph L Sacco; Ron Freudenberger; Susan Graham; John R Teerlink; Douglas Mann; Marco R Di Tullio; Piotr Ponikowski; Dirk J Lok; Stefan D Anker; Gregory Y H Lip; Conrado J Estol; Bruce Levin; Jay P Mohr; John L P Thompson; Shunichi Homma Journal: Cerebrovasc Dis Date: 2014-10-09 Impact factor: 2.762
Authors: Omar Saeed; Shuaiqi Zhang; Snehal R Patel; Ulrich P Jorde; Mario J Garcia; Nurilign Bulcha; Tanush Gupta; Ying Xian; Roland Matsouaka; Shreyansh Shah; Eric E Smith; Lee H Schwamm; Gregg C Fonarow Journal: J Card Fail Date: 2021-05-04 Impact factor: 6.592
Authors: Line Melgaard; Anders Gorst-Rasmussen; Lars Hvilsted Rasmussen; Gregory Y H Lip; Torben Bjerregaard Larsen Journal: PLoS One Date: 2016-03-25 Impact factor: 3.240
Authors: Azmil H Abdul-Rahim; Ana-Cristina Perez; Rachael L MacIsaac; Pardeep S Jhund; Brian L Claggett; Peter E Carson; Michel Komajda; Robert S McKelvie; Michael R Zile; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; Scott D Solomon; Gregory Y H Lip; Kennedy R Lees; John J V McMurray Journal: Eur Heart J Date: 2017-03-07 Impact factor: 29.983
Authors: Qi Zhao; Li Wang; Paul A Kurlansky; Jeff Schein; Onur Baser; Jeffrey S Berger Journal: BMC Cardiovasc Disord Date: 2019-01-15 Impact factor: 2.298